article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

Since companies test their own products—an obvious conflict of interest—they naturally design clinical trials to maximize evidence that they are beneficial and minimize evidence they are harmful. Safra Center for Ethics , some fellows study how these institutional practices corrupt medical science and clinical practice.

article thumbnail

At Olympus and Goldman Sachs, Two Very Different Whistleblowers

Harvard Business Review

For example, the SEC in 2010 had charged Goldman with misleading some of the parties to a billion dollar transaction (involving a complex derivative called a synthetic collateralized debt obligation), alleging specific facts about undisclosed conflicts of interest. Goldman settled within months for $550 million.

article thumbnail

How Pharma Can Fix Its Reputation and Its Business at the Same Time

Harvard Business Review

The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1% Ethical conduct is particularly important in emerging markets where companies rely heavily on governments’ goodwill for market access and health care investments. Enhance corporate reputations.